030sek
13,2 %
Date:2026-07-10Time:18:00:00Latest report:Q4-2026List:First NorthTicker:QCORE
Market Cap:13 msekEnterprise Value:8 msekNet Sales:6,74 msekEarnings:-36,5 msekEmployees:0ISIN:SE0016829824

Ratios

10-year key figure history for Qlucore turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Qlucore with index and moving average MA50 and MA200.

Stockprice:0,30
MA50:0,40
MA200:0,44
Price/MA200:-32,2 %
RSI (14):47,1
Price/MA50:-23,8 %

Description

Qlucore develops AI-based software for use in the healthcare sector. The company's precision medicine solutions transform genetic data into decision-making data to create the right treatment for patients. The company's first diagnostic test – for blood cancer in children – has been approved and CE-marked. The company also has tests for lung cancer under development, and is developing the Qlucore Omics Explorer analysis software.

IT Services